撤回：小豆蔻明通过中断由核因子κB受体活化因子配体激活的信号通路来抑制肿瘤细胞诱导的破骨细胞生成。
WITHDRAWN: Cardamonin Inhibits Osteoclastogenesis Induced by Tumor Cells Through Interruption of the Signaling Pathway Activated by Receptor Activator of NF-κB Ligand.
作者信息
Yadav Vivek R, Prasad Sahdeo, Reuter Simone, Sung Bokyung, Yamamoto Norio, Murakami Akira, Aggarwal Bharat B
机构信息
Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
出版信息
Cancer Lett. 2011 Dec 17. doi: 10.1016/j.canlet.2011.12.011.
Abstract
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.
摘要
本文已应作者和/或编辑的要求撤回。出版商对由此可能造成的任何不便表示歉意。爱思唯尔关于文章撤回的完整政策可在http://www.elsevier.com/locate/withdrawalpolicy上查阅。
相似文献
1
WITHDRAWN: Cardamonin Inhibits Osteoclastogenesis Induced by Tumor Cells Through Interruption of the Signaling Pathway Activated by Receptor Activator of NF-κB Ligand.撤回：小豆蔻明通过中断由核因子κB受体活化因子配体激活的信号通路来抑制肿瘤细胞诱导的破骨细胞生成。
Cancer Lett. 2011 Dec 17. doi: 10.1016/j.canlet.2011.12.011.
2
WITHDRAWN: fMRI correlates of visual working memory: What vs. where.撤回：视觉工作记忆的功能磁共振成像相关性：什么与哪里。
Neuroimage. 2011 Oct 14. doi: 10.1016/j.neuroimage.2011.10.017.
3
WITHDRAWN: Letter to the Editor.撤回：致编辑的信。
Phytomedicine. 2006 Jun 30. doi: 10.1016/j.phymed.2006.02.010.
4
WITHDRAWN: Letter to the Editor.撤回：致编辑的信。
Vaccine. 2011 Jul 23. doi: 10.1016/j.vaccine.2011.07.085.
5
WITHDRAWN: Letter to the editor.撤回：致编辑的信。
Vaccine. 2004 Aug 13. doi: 10.1016/j.vaccine.2004.07.011.
6
WITHDRAWN: Reply to Letter to the Editor.撤回：致编辑信件的回复。
Eur J Radiol. 2006 Jan 25. doi: 10.1016/j.ejrad.2005.12.010.
7
WITHDRAWN: Letters to the Editor/Errata.撤回：致编辑的信/勘误。
J Urol. 2010 Sep 22. doi: 10.1016/j.juro.2010.06.168.
8
WITHDRAWN: Toll-like receptor-4 Signaling Improved the Migration of Sca-1stem/progenitor Cells.
Ann Vasc Surg. 2017 Jul 21. doi: 10.1016/j.avsg.2017.07.022.
9
WITHDRAWN:2',4',7-Trihydroxyisoflavon (THF) inhibits heat-shock-induced matrix metalloproteinase-1 expression in human dermal fibroblasts.
Phytomedicine. 2006 May 2. doi: 10.1016/j.phymed.2006.02.006.
10
WITHDRAWN: Survivin, Caspase-3 and Caspase-9-activated proteins kinases in apoptosis.
Int J Biol Macromol. 2013 Apr 18. doi: 10.1016/j.ijbiomac.2013.04.039.
本文引用的文献
1
Cardamonin suppresses nitric oxide production via blocking the IFN-γ/STAT pathway in endotoxin-challenged peritoneal macrophages of ICR mice.小豆蔻明通过阻断 IFN-γ/STAT 通路抑制内毒素诱导的 ICR 小鼠腹腔巨噬细胞一氧化氮的产生。
Life Sci. 2011 Aug 29;89(9-10):337-42. doi: 10.1016/j.lfs.2011.06.027. Epub 2011 Jul 20.
2
Bone metastasis in prostate cancer: emerging therapeutic strategies.前列腺癌的骨转移：新兴的治疗策略。
Nat Rev Clin Oncol. 2011 Jun;8(6):357-68. doi: 10.1038/nrclinonc.2011.67. Epub 2011 May 10.
3
Embelin suppresses osteoclastogenesis induced by receptor activator of NF-κB ligand and tumor cells in vitro through inhibition of the NF-κB cell signaling pathway.鞣花酸通过抑制 NF-κB 细胞信号通路体外抑制核因子-κB 配体和肿瘤细胞诱导的破骨细胞生成。
Mol Cancer Res. 2010 Oct;8(10):1425-36. doi: 10.1158/1541-7786.MCR-10-0141. Epub 2010 Sep 8.
4
Future directions of bone-targeted therapy for metastatic breast cancer.转移性乳腺癌骨靶向治疗的未来方向。
Nat Rev Clin Oncol. 2010 Nov;7(11):641-51. doi: 10.1038/nrclinonc.2010.134. Epub 2010 Aug 31.
5
NF-kappaB modulators in osteolytic bone diseases.溶骨性骨疾病中的核因子-κB调节剂
Cytokine Growth Factor Rev. 2009 Feb;20(1):7-17. doi: 10.1016/j.cytogfr.2008.11.007. Epub 2008 Nov 28.
6
Osteoclastogenesis--current knowledge and future perspectives.破骨细胞生成——当前认知与未来展望
J Musculoskelet Neuronal Interact. 2008 Jul-Sep;8(3):204-16.
7
Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice.去泛素化酶CYLD对小鼠中的RANK信号传导和破骨细胞生成起负向调节作用。
J Clin Invest. 2008 May;118(5):1858-66. doi: 10.1172/JCI34257.
8
Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.核因子κB受体活化因子配体与骨保护素在健康与疾病状态下对骨重塑的调节作用
Endocr Rev. 2008 Apr;29(2):155-92. doi: 10.1210/er.2007-0014. Epub 2007 Dec 5.
9
Targeting NF-kappaB pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growth.用IKK2抑制剂靶向NF-κB通路可诱导多发性骨髓瘤细胞生长受到抑制。
Br J Haematol. 2007 Jul;138(2):160-8. doi: 10.1111/j.1365-2141.2007.06629.x. Epub 2007 Jun 3.
10
American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma.美国临床肿瘤学会2007年关于双膦酸盐在多发性骨髓瘤中作用的临床实践指南更新
J Clin Oncol. 2007 Jun 10;25(17):2464-72. doi: 10.1200/JCO.2007.12.1269. Epub 2007 May 21.
Zotero 插件